Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
R2 Innovations, Inc. logo — Delivering alternative methods, processes and delivery syste...

R2 Innovations, Inc.

Delivering alternative methods, processes and delivery systems to the legal Cannabinoid and Tobacco industries globally.

Founded 1998 United States Centennial, United States 2 employees

General Information

Company Name R2 Innovations, Inc.
Founded Year 1998
Location United States Centennial, United States +3
Employees 2
Social

Get notified when R2 Innovations, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About R2 Innovations, Inc.

ABOUT R2 INNOVATIONS THE COMPANY R2 Innovations, LLC was founded by Robert L. Senter and Robert E. Matuszewski in 1998 a privately owned, Colorado Limited Liability Company. R2 has arranged equity partnerships with industry leaders in the field of drying and micronizing microparticles and nanoparticles into dry powder aerosols for the purpose of inhalation therapies, targeting the treatment of respiratory diseases, including asthma, emphysema and COPD. In addition to dry powder formulations targeting pulmonary and respiratory disorders; US patent pending processes, research and studies are underway to convert CBD, cannabidiol and other cannabis derived, extracted oils into pharmaceutical grade, fine powder formulations using R2’s pressurized, metered dose inhaler (pMDI) and R2's dry powder inhaler (DPI) technologies directed at treating stress, post traumatic stress disorders (PTSD), anti-inflammatory pain relief and insomnia. R2 MISSION R2’s Mission is to be recognized as a global leader in the development and manufacturing of natural medicines to treat specific, targeted ailments and diseases. At R2 we are devoted to delivering alternative medical treatments to solve ongoing medical problems and support important advancements in medical science. R2 OBJECTIVE R2’s objective is to challenge the use of; fluticasone propionate/salmeterol xinafoate, budesonide/formoterol, albuterol/salbutamol, budesonide, fluticasone and formoterol fumarate as the preferred corticosteroid medical treatments in existing metered dose inhalers eliminating adverse side effects, and the threat of death with overdosing for asthmatic, COPD and Emphysema patients. R2 VISION R2's Vision is to lead the global marketplace in advanced alternative medicines with an emphasis on respiratory therapies, supported by clinical research, double blind studies and independent lab testing.

No funding data available for R2 Innovations, Inc. yet.

Get notified when R2 Innovations, Inc. raises funding

FAQ About R2 Innovations, Inc.

Delivering alternative methods, processes and delivery systems to the legal Cannabinoid and Tobacco industries globally.
R2 Innovations, Inc. was founded in 1998.
R2 Innovations, Inc. is headquartered in Centennial, United States.
R2 Innovations, Inc. has approximately 2 employees.

We're actively collecting intelligence on R2 Innovations, Inc..

Track R2 Innovations, Inc. to get notified

Don't just browse. Track.

Signal Tracker monitors R2 Innovations, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy